Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
New FDA Dietary Supplement Draft Guidance Seeks To Prevent Public Safety Problems August 12, 2016 Irvin Jackson Add Your Comments In response to mounting concerns about the safety of dietary supplements, which are not tightly regulated by the FDA, the regulatory agency has proposed new guidelines that call for the manufacturers to notify the agency when a product might include new ingredients that have not been thoroughly tested for safety. The FDA announced the revised draft guidance for dietary supplements on August 11. The guidance is an attempt to prevent public harm from the supplements, which the FDA cannot regulate unless they cause a public health problem. While most dietary supplements are sold in the United States without FDA oversight, the Dietary Supplement Health and Education Act (DSHEA) requires a manufacturer or distributor to notify the agency at least 75 days before it puts a supplement on the market that contains a new dietary ingredient (NDI) not marketed in the U.S. before October 15, 1994. The only exception is if the NDI is already used in the food supply without chemical alteration. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This draft guidance instructs the companies how and when such notifications are necessary. It explains what qualifies as an NDI, when notification is required, how to submit an NDI notification, how to evaluate the safety of an NDI and what information the FDA needs to have. “This revised draft guidance is an important step forward in the agency’s work to protect public health from potentially dangerous new dietary ingredients,” Steve Tave, acting director of the FDA’s Office of Dietary Supplement Programs, said in a press release. “Notification of new dietary ingredients is the only pre-market opportunity the agency has to identify unsafe supplements before they are available to consumers. The revised draft guidance is intended to improve the quality of industry’s new dietary ingredient reporting so the FDA can more effectively monitor the safety of dietary supplements.” Critics say that the NDI rule is often too easily sidestepped. In a report in response to the guidance, Consumer Reports notes that chemicals already in the food supply are exempt even if manufacturers use them in a way that is potentially dangerous, citing pure powdered caffeine as one example. In July 2014, the FDA issued a safety advisory about the potential health risks of powdered caffeine, warning consumers to avoid using the products after they were linked to reports of serious injury and death. A recent investigation by the FDA has also shown an increase in hospitalizations from caffeine toxicity reported across the country in recent years, stemming from the use of energy drinks, shots and other products containing high amounts of caffeine and other stimulants. With the popularity of pure powdered caffeine growing, the FDA has recorded an increased number of hospitalizations from toxic caffeine levels in younger generations across the country in recent years. Many of the cases are directly related to the use of energy drinks, energy shots, and other harmful caffeine stimulants labeled as “All Natural.” However, because caffeine has been used in the food supply for centuries, the more dangerous powdered caffeine products are exempt from the NDI rule. Consumer Reports claims manufacturers have scoffed at the NDI rule, noting that there are more than 90,000 dietary supplements on the market, with 5,560 new ones introduced annually. However, the FDA has received less than 1,000 NDI notifications over the past 20 years. The new draft is a revision of one originally released in 2011, but the FDA indicates that there were several points that appear to have not been fully understood. Tags: Caffeine, Caffeine Powder, Dietary Supplement More Lawsuit Stories Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks March 21, 2025 McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection March 21, 2025 Elevidys Side Effects Suspected in Liver Failure, Death of Duchenne Muscular Dystrophy Patient March 21, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: today) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025) McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: today) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023) Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: yesterday) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025)
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks March 21, 2025
McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection March 21, 2025
Elevidys Side Effects Suspected in Liver Failure, Death of Duchenne Muscular Dystrophy Patient March 21, 2025
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: today) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
McKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (Posted: today) An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITSteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: yesterday) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025)